A similar conclusion was made by Santos et al. [39] when they tested 3a against estrogen-receptor-positive breast cancer cells MCF-7 and the triple-negative breast cancer (TNBC) cells MDA-MB-23. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.